Regen BioPharma, Inc. Financial Ratios — RGBP Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-1,195.09	-1,913.15	-1,264.72	-924.19	-817.72	-1,702.78	2,457.79	-1,013.3	251.49	224.3	-259.67	-585.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-23.31	- -	-12.7	-5.69	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-1,030.87	-2,956.96	-2,282.62	-1,425.78	-687.99	-190.29	-117.28	-144.2	-290.39	-176.37	-143.11
Operating Margin (%)	- -	- -	-1,030.87	-2,956.96	-2,282.62	-1,425.78	-687.99	-190.29	-117.28	-144.2	-290.39	-176.37	-143.11
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	3,104.02	-3,951.79	1,037.52	488.89	-282.49	-538.76
Profit Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	2,483.21	-3,951.79	945.59	432.66	-282.49	-538.76
Net Income to Common Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	2,483.21	-3,951.79	945.59	432.66	-282.49	-538.76
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	- -	1	1	2	3	4	1	1	1	1
ST Debt	- -	- -	- -	- -	- -	1	2	3	4	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-0.18	-0.11	-0.09	-0.28	-1	-2.84	-12.44	-17.85	-3.75	-1.1	-1.9	-3.54
Net Debt/EBITDA	0.36	-0.18	-0.09	-0.08	-0.17	-1	-2.83	-12.44	-14.22	-3.6	-0.92	-1.9	-3.33
Total Debt/EBIT	- -	-0.18	-0.11	-0.09	-0.28	-1	-2.84	-12.44	-17.85	-3.75	-1.1	-1.9	-3.54
Net Debt/EBIT	0.36	-0.18	-0.09	-0.08	-0.17	-1	-2.83	-12.44	-14.22	-3.6	-0.92	-1.9	-3.33
EBITDA to Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
EBITDA-CapEx/Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
EBIT to Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
Interest Expense	- -	- -	- -	- -	1	2	2	1	- -	- -	- -	- -	- -
Common Equity/Total Assets	-446.04	-11,951.07	-1,577.59	-2,157.1	-1,347.95	-8,343.31	-20,121.8	-13,331.68	-1,890.43	-3,649.76	-5,584.72	-12,674.5	-7,897.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.62	-2.77	-4.11	-0.03	- -	- -	- -	-0.79	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	33.52	35.2	314.41	5.02	- -	- -	- -	42.31	- -	- -
Total Debt/Equity (%)	- -	-97.44	-229.2	-44.22	-13.19	-15.7	-19.68	-35.51	-26.57	-15.85	-14.8	-15.21	-19.07
Total Debt/Capital (%)	- -	-11.01	-6.86	-3.92	-5.76	-8.96	-12.1	-18.91	-18.58	-6.68	-3.98	-4.04	-5.85
Total Debt/Total Assets (%)	- -	1,185.42	101.04	81.27	73.36	685.24	2,166.98	2,114.55	295.6	227.92	213.57	492.72	436.18
Net Debt to Equity	-100	-97.44	-189.46	-39.99	-8.05	-15.61	-19.61	-35.51	-21.18	-15.22	-12.42	-15.2	-17.96
Net Debt/Capital (%)	18.31	-11.01	-5.6	-3.53	-3.44	-8.9	-12.05	-18.91	-14.27	-6.39	-3.32	-4.04	-5.49
EBITDA	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
EBITDA-CapEx	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
Operating Income (Loss)	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -

Liquidity (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	- -	- -	0.12	0.03	0.05	- -	- -	- -	0.05	0.01	0.02	- -	0.01
Current Ratio	- -	0.08	0.2	0.26	0.08	- -	0.01	0.01	0.07	0.04	0.02	0.03	0.04
Quick Ratio	- -	0.08	0.16	0.17	0.08	- -	0.01	0.01	0.06	0.04	0.02	0.02	0.04
CFO/Avg Current Liab	- -	-10.65	-5.21	-2.99	-0.57	-0.22	-0.05	- -	-0.1	-0.05	-0.03	-0.14	-0.06
Common Equity/Total Assets	-446.04	-11,951.07	-1,577.59	-2,157.1	-1,347.95	-8,343.31	-20,121.8	-13,331.68	-1,890.43	-3,649.76	-5,584.72	-12,674.5	-7,897.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.62	-2.77	-4.11	-0.03	- -	- -	- -	-0.79	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	33.52	35.2	314.41	5.02	- -	- -	- -	42.31	- -	- -
Total Debt/Equity (%)	- -	-97.44	-229.2	-44.22	-13.19	-15.7	-19.68	-35.51	-26.57	-15.85	-14.8	-15.21	-19.07
Total Debt/Capital (%)	- -	-11.01	-6.86	-3.92	-5.76	-8.96	-12.1	-18.91	-18.58	-6.68	-3.98	-4.04	-5.85
Total Debt/Total Assets (%)	- -	1,185.42	101.04	81.27	73.36	685.24	2,166.98	2,114.55	295.6	227.92	213.57	492.72	436.18
CFO/Total Liabilities	- -	-532.41	-375.47	-184.52	-30.58	-16.91	-4.38	0.25	-7.69	-7.06	-3.19	-13.97	-5.85
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	-365.96	-20.66	-52.15	-33.75	-188.39	-438.82	-264.79	-37.19	-69.53	-100.8	-223.4	-141.2

Working Capital (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	- -	- -	- -	2.41	2.65	- -	3.09	1.26	1.08	1.01	1.86	4.99	1.58
Days Sales Outstanding	- -	- -	- -	151.48	137.7	- -	118.1	289.31	337.28	362.23	196.17	73.19	231.25
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	8	17	16	7	2	2	- -	92	31	6	1	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	1	1	2	3	4	1	1	1	1
Enterprise Value	- -	8	17	16	7	3	4	3	95	32	7	2	1
Total Capital	-1	-1	-3	-7	-12	-16	-18	-14	-19	-19	-19	-20	-20
Total Debt/Capital (%)	- -	-11.01	-6.86	-3.92	-5.76	-8.96	-12.1	-18.91	-18.58	-6.68	-3.98	-4.04	-5.85
Total Debt / EV	- -	0.02	0.01	0.02	0.1	0.44	0.48	0.85	0.04	0.04	0.11	0.42	0.83
EV/Sales	- -	- -	88.26	162.3	64.3	32.39	40.51	27.91	553.15	135.35	29.67	7.92	6.12
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	3.65	3.19	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	3.65	3.19	- -	- -	- -	- -	- -
Diluted Market Cap	- -	8	17	16	7	2	2	- -	92	31	6	1	- -
Diluted Enterprise Value	- -	8	17	16	7	3	4	3	95	32	7	2	1
EV per Share	- -	121.83	144.12	95.22	37.51	15.97	1.61	1.63	23.58	5.08	0.99	0.18	0.06
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
TTM Operating Income	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
TTM Cash Flow to Firm	- -	-1	-1	-2	-1	- -	1	1	-1	- -	- -	-1	- -
TTM Free Cash Flow to Firm	- -	-1	-1	-2	-1	- -	1	1	-1	- -	- -	-1	- -

Multiples (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	-11.08	-14.05	-9.56	-3.5	-1.14	-4.73	22.68	-81.16	-50.43	-36.71	-1.44	-0.83
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	8	17	16	7	3	4	3	95	32	7	2	1
Low Price	- -	7.5	0.08	49.14	13.5	7.44	0.38	- -	0.15	2.58	0.52	0.06	0.01
EV/Sales	- -	- -	88.26	162.3	64.3	32.39	40.51	27.91	553.15	135.35	29.67	7.92	6.12
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	0.15	- -	13.74	6.24	- -	- -
Price/Earnings Average	- -	-16.22	-7.03	-4.85	-1.44	-1.19	-2.21	0.15	-5.73	22.06	13.48	-6.59	-1.29
Price/Earnings High	- -	-68.39	-17.87	-8.2	-3.14	-4.12	-11.54	0.98	-36.47	75.36	37.87	-15.42	-4.98
Price/Earnings Low	- -	-0.68	- -	-2.45	-0.44	-0.32	-0.39	- -	-0.09	7.27	3.56	-0.91	-0.2
Price/Book Value	- -	-6.5	-4.82	-2.32	-0.52	-0.1	-0.11	-0.03	-4.01	-1.5	-0.32	-0.05	-0.01
Price/Book Value Average	- -	-9.64	-4.47	-2.4	-0.66	-0.32	-0.29	-0.02	-1.69	-2.41	-0.7	-0.22	-0.08
Price/Book Value High	- -	-40.62	-11.36	-4.06	-1.44	-1.11	-1.52	-0.16	-10.77	-8.23	-1.96	-0.5	-0.29
Price/Book Value Low	- -	-0.41	- -	-1.22	-0.2	-0.09	-0.05	- -	-0.03	-0.79	-0.18	-0.03	-0.01
Price/Tangible Book Value	- -	-63.85	-162.22	-26.62	-1.26	-0.2	-0.21	-0.06	-6.78	-3.79	-1.25	-0.21	-0.05
Price/Tangible Book Value Average	- -	-94.67	-150.4	-27.57	-1.6	-0.61	-0.53	-0.05	-2.86	-6.08	-2.7	-0.84	-0.26
Price/Tangible Book Value High	- -	-399.06	-382.49	-46.63	-3.48	-2.13	-2.76	-0.36	-18.23	-20.76	-7.59	-1.97	-1.01
Price/Tangible Book Value Low	- -	-3.99	-0.09	-13.95	-0.48	-0.17	-0.09	- -	-0.04	-2	-0.71	-0.12	-0.04
Price/Sales	- -	- -	87.27	159.82	60.31	17.97	20.71	3.85	536.19	129.95	26.99	4.57	1.34
Price/Sales Average	- -	- -	80.91	165.53	76.43	56.14	52.82	3.63	226.48	208.62	58.33	18.62	6.96
Price/Sales High	- -	- -	205.76	279.99	166.52	194.27	275.15	24.44	1,441.09	712.6	163.87	43.57	26.85
Price/Sales Low	- -	- -	0.05	83.76	23.14	15.09	9.41	0.01	3.52	68.7	15.4	2.56	1.06
Price/Cash Flow	- -	-11.08	-14.05	-9.56	-3.5	-1.14	-4.73	22.68	-81.16	-50.43	-36.71	-1.44	-0.83
Price/Cash Flow Average	- -	-16.43	-13.03	-9.9	-4.44	-3.56	-12.06	21.41	-34.28	-80.95	-79.35	-5.86	-4.29
Price/Cash Flow High	- -	-69.26	-33.13	-16.74	-9.67	-12.31	-62.82	144.17	-218.14	-276.53	-222.89	-13.71	-16.56
Price/Cash Flow Low	- -	-0.69	-0.01	-5.01	-1.34	-0.96	-2.15	0.08	-0.53	-26.66	-20.95	-0.81	-0.66
Price/Free Cash Flow Average	- -	-16.43	-13.03	-9.9	-4.44	-3.56	-12.06	21.41	-34.28	-80.95	-79.35	-5.86	-4.29
Price/Free Cash Flow High	- -	-69.26	-33.13	-16.74	-9.67	-12.31	-62.82	144.17	-218.14	-276.53	-222.89	-13.71	-16.56
Price/Free Cash Flow Low	- -	-0.69	-0.01	-5.01	-1.34	-0.96	-2.15	0.08	-0.53	-26.66	-20.95	-0.81	-0.66
EV/Sales Average	- -	- -	81.9	168.01	80.42	70.57	72.62	27.7	243.44	214.02	61.02	21.97	11.73
EV/Sales High	- -	- -	206.76	282.47	170.52	208.69	294.95	48.51	1,458.05	718	166.55	46.92	31.62
EV/Sales Low	- -	- -	1.04	86.24	27.14	29.51	29.21	24.08	20.48	74.1	18.08	5.92	5.84
EV/EBITDA Average	0.36	-17.55	-7.94	-5.68	-3.52	-4.95	-10.56	-14.55	-207.58	-148.42	-21.01	-12.46	-8.2
EV/EBITDA High	0.36	-73.41	-20.06	-9.55	-7.47	-14.64	-42.87	-25.49	-1,243.26	-497.94	-57.35	-26.6	-22.1
EV/EBITDA Low	0.36	-0.91	-0.1	-2.92	-1.19	-2.07	-4.25	-12.65	-17.46	-51.39	-6.23	-3.35	-4.08
EV/EBIT Average	0.36	-17.55	-7.94	-5.68	-3.52	-4.95	-10.56	-14.55	-207.58	-148.42	-21.01	-12.46	-8.2
EV/EBIT High	0.36	-73.41	-20.06	-9.55	-7.47	-14.64	-42.87	-25.49	-1,243.26	-497.94	-57.35	-26.6	-22.1
EV/EBIT Low	0.36	-0.91	-0.1	-2.92	-1.19	-2.07	-4.25	-12.65	-17.46	-51.39	-6.23	-3.35	-4.08
Last Price	- -	120	142.5	93.76	35.18	8.86	0.82	0.22	22.86	4.88	0.9	0.1	0.01
High Price	- -	750	336	164.26	97.14	95.8	10.96	1.43	61.44	26.76	5.48	0.98	0.27
Enterprise Value Average	- -	12	16	17	9	7	8	3	42	50	14	5	3
Enterprise Value High	- -	52	40	28	19	21	32	5	250	169	39	11	7
Enterprise Value Low	- -	1	- -	9	3	3	3	3	4	17	4	1	1

Shares Outstanding	- -	- -	- -	- -	- -	- -	1	2	6	7	7	11	39
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	3	2	4	6	7	11	24
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	3	2	4	6	7	11	24
Revenue per Share	- -	- -	1.63	0.59	0.58	0.49	0.04	0.06	0.04	0.04	0.03	0.02	0.01
EBITDA per Share	-12.66	-10.24	-16.83	-17.35	-13.32	-7.03	-0.27	-0.11	-0.05	-0.05	-0.1	-0.04	-0.01
Operating Income per Share	-12.66	-10.24	-16.83	-17.35	-13.32	-7.03	-0.27	-0.11	-0.05	-0.05	-0.1	-0.04	-0.01
Basic EPS, GAAP	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.45	-1.68	0.36	0.14	-0.06	-0.05
Basic EPS from Cont Ops	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.82	-1.68	0.39	0.16	-0.06	-0.05
Diluted EPS, GAAP	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.45	-1.68	0.36	0.14	-0.06	-0.05
Diluted EPS from Cont Ops	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.82	-1.68	0.39	0.16	-0.06	-0.05
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-11.27	-10.83	-10.14	-9.81	-10.05	-7.78	-0.17	0.01	-0.28	-0.1	-0.02	-0.07	-0.02
Free Cash Flow per Basic Share	-11.27	-10.83	-10.14	-9.81	-10.05	-7.78	-0.17	0.01	-0.28	-0.1	-0.02	-0.07	-0.02
Cash & Equivalents per Share	4.59	- -	0.33	0.15	1.43	0.04	- -	- -	0.18	0.01	0.02	- -	- -
Book Value per Share	-20.46	-18.46	-29.58	-40.41	-67.5	-86	-7.22	-8.74	-5.71	-3.25	-2.79	-1.94	-0.92
Tangible Book Value per Share	4.59	-1.88	-0.88	-3.52	-27.94	-45.07	-3.96	-3.92	-3.37	-1.29	-0.72	-0.5	-0.27

Regen BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)